A detailed history of Northwest Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Northwest Capital Management Inc holds 1,422 shares of PFE stock, worth $37,995. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,422
Previous 1,422 -0.0%
Holding current value
$37,995
Previous $41,000 -0.0%
% of portfolio
0.02%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$27.7 - $31.39 $27 - $31
-1 Reduced 0.07%
1,422 $41,000
Q2 2024

Jul 09, 2024

SELL
$25.26 - $29.6 $9,043 - $10,596
-358 Reduced 20.1%
1,423 $39,000
Q4 2023

Feb 01, 2024

BUY
$26.13 - $33.94 $2,038 - $2,647
78 Added 4.58%
1,781 $51,000
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $866 - $1,012
-27 Reduced 1.56%
1,703 $56,000
Q2 2023

Aug 03, 2023

BUY
$36.12 - $41.79 $62,487 - $72,296
1,730 New
1,730 $63,000
Q3 2022

Nov 07, 2022

BUY
$43.76 - $53.42 $230,396 - $281,256
5,265 New
5,265 $230,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Northwest Capital Management Inc Portfolio

Follow Northwest Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Capital Management Inc with notifications on news.